Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension
| dc.contributor.author | Візір, Марина Олександрівна | |
| dc.contributor.author | Vizir, Maryna | |
| dc.contributor.author | Визир, Марина Александровна | |
| dc.date.accessioned | 2019-06-14T10:50:28Z | |
| dc.date.available | 2019-06-14T10:50:28Z | |
| dc.date.issued | 2019-05-25 | |
| dc.description.abstract | Nesfatin-1 was discovered in 2006 as a satiety peptide produced by hypothalamus and adipose tissue mainly. It was found that activity of nesfatin-1 may be related to the occurrence of hypertension, obesity, type 2 diabetes mellitus and thereby affect the cardiometabolic risk. However, the mechanisms which lead to progressive deterioration after long-term hypertension remain unclear. | ru_RU |
| dc.identifier.citation | Vizir M. Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension / М. Vizir // European Journal of Heart Failure. 2019. – Vol. 21, suppl. S1. – P. 133. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/23474 | |
| dc.language.iso | en | ru_RU |
| dc.publisher | European Society of Cardiology | ru_RU |
| dc.subject | nesfatin-1 | ru_RU |
| dc.subject | cardiometabolic risk | ru_RU |
| dc.subject | obesity | ru_RU |
| dc.subject | duration of hypertension | ru_RU |
| dc.title | Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension | ru_RU |
| dc.type | Thesis | ru_RU |